The Honourable Tony Clement, Federal Minister of Health, and the Honourable George Smitherman, Health Minister of Ontario, announced that Ontario will establish a Patient Wait Times Guarantee for cataract surgery by January 1, 2009, to be supported by $205 million in federal funding.
Researchers at Melbourne?s Howard Florey Institute have opened up new treatment possibilities for Huntington?s disease by proving a scientific theory incorrect.
Older women with breast cancer get a lower level of care than younger women, researchers at the University of Manchester have found.
Researchers at UC San Diego have discovered that iron-containing nanoparticles being tested for use in several biomedical applications can be toxic to nerve cells and interfere with the formation of their signal-transmitting extensions.
The CNS Foundation welcomes the publication by CNS grantee Dr. Evan Snyder of experimental results that extend the promise of stem cell therapies to degenerative brain diseases of childhood.
Women in their 70s who keep active could be dodging painful arthritis symptoms, according to research published today in Arthritis Research & Therapy. The study is the first to show that the more you exercise, the better your chances of preventing the onset of stiff and painful joints.
A common asthma inhaler powered by a new propellant is safe and effective but could come at nearly triple the cost to consumers until a generic version hits the market, according to a review in today’s (March 29) New England Journal of Medicine.
For the millions of Americans whose vision is slowly ebbing due to degenerative diseases of the eye, the lowly neural progenitor cell may be riding to the rescue.
Alan Garen, professor of molecular biophysics and biochemistry at Yale has received a $100,000 award from the Prostate Cancer Foundation to expand research on the delivery of a targeted therapy for prostate cancer using nanoparticles.
Women with a recent diagnosis of cancer in one breast should have MRI screening of the opposite breast, concludes a multi-center study involving University of North Carolina at Chapel Hill researchers.